Cencora solution

Regulatory writing

Turn complex scientific, clinical, and quality data into clear, accurate, submission-ready documents across development and lifecycle management.
Available for
  • Pharma
Available in
  • Global
Related capabilities
  • Commercialization support

Strengthen development and submission writing

High-quality writing connects scientific evidence, product knowledge, and regulatory requirements. Across medical, nonclinical, clinical and CMC content, documents must be accurate, consistent, traceable and fit for their intended audience. 
 
Cencora brings together specialized writers and subject-matter experts to support individual deliverables or integrated writing programs across development, registration and post-approval lifecycle management. 
 
Supported by global, regional and local expertise, our teams help strengthen scientific accuracy, consistency and regulatory compliance across development programs and international markets.

Address documentation risks across the lifecycle

Writing programs must balance complex source data, multiple contributors, evolving requirements and demanding timelines. Cencora helps reduce the issues that most often delay progress and increase submission risk.
Complex requirements
Requirements vary by document type, product, development stage, region and target audience, making it harder to keep content scientifically robust and aligned.
Cross-functional alignment
Medical, nonclinical, clinical, CMC, regulatory and operational contributors must work from consistent evidence, terminology and messages across documents.
Time and quality pressure
Compressed timelines, fluctuating workloads and inconsistent content can trigger rework, review questions and avoidable pressure on internal teams.

Comprehensive writing support

You get medical, scientific and CMC writing support for small molecules, biologics, biosimilars, and ATMPs across development, registration and post-approval lifecycle management, from planning and authoring to review, QC and submission readiness.

Our specialized writers, CMC experts, and regulatory professionals support stand-alone deliverables, capacity overflow, and scalable writing programs.

What we offer

Clinical writing

Clinical development plans, protocols, investigator brochures, clinical study reports, overviews, summaries and other submission-support content across development milestones.

Nonclinical writing

Nonclinical plans, protocols, reports, summaries, overviews and literature-based assessments to support scientifically robust documentation and regulatory communication.

CMC dossier writing

Authoring, review and compilation of quality content for development, submissions, health authority responses and interactions, post-approval changes, remediations, harmonization, and regional rollout activities.

Expert quality reports

Quality reports covering impurities, nitrosamines, excipients, product development and analytical assessments to support submissions and ongoing product maintenance.

Global program delivery

Global and regional Centers of Excellence provide scalable support, including planning, source review, authoring and submission readiness.

Quality control

Technical review, QC review, comment reconciliation, cross-document consistency checks, data management and systems archiving for coordinated document delivery.

Why choose Cencora for regulatory writing

Specialized expertise

Medical, scientific, CMC and regulatory experts support accurate, fit-for-purpose documents across development, submissions and lifecycle activities.

Scalable engagement options

Individual deliverables, capacity support and scalable writing programs align resources to program needs, timelines and internal team structures.

Integrated document support

Cross-functional support connects clinical, nonclinical, CMC, quality and regulatory inputs for clearer, more consistent submission-ready documentation.

Expert insight

Regulators expect not only valid results, but also a coherent explanation of how each dataset supports product quality, safety, and efficacy.

— Michael Day, PhD

RAPS Convergence 2025: Transparency, Trust, and Resilience in Regulatory Science

Related solutions

Integrated submission readiness assessment
Navigate NDA, BLA, and MAA submissions with cross-functional regulatory support and an independent readiness assessment before filing.
  • Commercialization support
  • Pharma
  • Global
Publishing and electronic submission services
Run regulatory publishing and electronic submissions end to end, from planning and eCTD assembly through validation, publishing, and lifecycle maintenance.
  • Commercialization support
  • Pharma
  • Global
Health authority interactions
We help life sciences teams navigate health authority interactions across development, review, and post-approval with clear strategy and actionable guidance.
  • Commercialization support
  • Pharma
  • Global

Related resources

Data on ipad - PV essential guide white paper

Article

As eCTD 4.0 adoption inches forward, a new ICH guideline puts it to the test
People Sitting On Chairs In Seminar

Article

RAPS Convergence 2025: Transparency, Trust, and Resilience in Regulatory Science
A man and a woman are sitting at a computer and discussing what is on the monitor

Article

The brave new world of predictive AI: Redefining the benefit-risk journey

PharmaLex is now Cencora

Regulatory writing is part of our Commercialization support capability. Same team, same expertise, now with greater reach.
 

Need more information about regulatory writing?

Our team of experts is here to assist you. Whether you have questions or need more detailed information, don’t hesitate to get in touch. We’re dedicated to providing the support you need.